Occurrence and Removal of Pharmaceutical Contaminants in Urine: A Review

Xiaolin Li, Bin Wang, Feng Liu, Gang YuWater 2023 · DOI

TL;DR

Pharmaceuticals are a growing concern in wastewater, with human urine being a particularly concentrated source. This review synthesizes current knowledge on pharmaceutical contamination in urine, their metabolic pathways, and critically evaluates treatment technologies, highlighting advanced oxidation processes, especially electrochemical oxidation, as promising solutions for urine valorization.

What Problem Does This Paper Address?

The widespread use of pharmaceuticals has led to their detection in various environmental compartments, raising concerns about their potential toxicity, persistence, and impact on ecosystems and human health. While source-separated urine offers a valuable resource for nutrient recovery, the presence of pharmaceuticals complicates its direct reuse. Traditional wastewater treatment plants (WWTPs) are often inefficient at removing these contaminants, leading to their discharge into the environment. This paper addresses the critical need to understand and effectively remove pharmaceutical contaminants from source-separated urine to enable its safe and sustainable resource recovery.

Methods

This review is based on a comprehensive literature search using Web of Science. The authors employed specific search terms to identify relevant peer-reviewed papers focusing on:

  • Classification, sources, and metabolic pathways of pharmaceutical contaminants.
  • Pharmaceutical contamination in human urine, WWTPs, and surface water.
  • Research progress in urine treatment technologies, particularly advanced oxidation and electrochemical methods.

The gathered information was then analyzed and synthesized to provide a structured overview of the current state of knowledge and research progress.

Datasets

Not discussed in the paper. The paper is a review article and synthesizes data from numerous existing studies rather than presenting new experimental data or datasets.

Key Insights and Ideas

  • Urine as a Concentrated Source: Human urine is a primary excretion route for pharmaceuticals, leading to concentrations in urine that are 2-3 orders of magnitude higher than in municipal wastewater treatment plant influents and surface waters. This makes urine a critical point for intervention.
  • Metabolic Pathways Matter: Understanding how the human body metabolizes pharmaceuticals is crucial, as both parent compounds and their metabolites can be excreted and pose environmental risks. Urinary excretion is identified as the dominant pathway.
  • Limitations of Conventional Treatment: Standard wastewater treatment processes are largely ineffective at removing pharmaceutical contaminants, with removal efficiencies often as low as 20-30%.
  • Advanced Oxidation Processes (AOPs) Shine: AOPs, particularly electrochemical oxidation (EO), show significant promise for degrading persistent pharmaceutical contaminants in urine due to their cleanness, flexibility, and controllability.
  • Electrode Material is Key: The choice of electrode material in EO is critical for treatment efficiency and cost-effectiveness. Boron-doped diamond (BDD) electrodes are effective but expensive, driving research into more affordable alternatives like mixed metal oxide (MMO) electrodes.
  • Cost Remains a Hurdle: While electrochemical technology is advancing, its high cost is a significant barrier to widespread adoption, necessitating further research into cost-reduction strategies.

Key Results

  • Pharmaceutical concentrations in human urine are significantly higher (2-3 orders of magnitude) than in sewage plants and surface water.
  • Traditional WWTPs show limited removal efficiency (20-30%) for pharmaceutical contaminants.
  • Advanced oxidation technologies, especially electrochemical oxidation, are identified as promising for treating pharmaceutical contaminants in urine.
  • Research on electrode materials for EO is ongoing, with a focus on developing cost-effective and stable options.
  • The paper reviews numerous studies demonstrating the effectiveness of various physical, biological, and chemical treatment methods for specific pharmaceuticals in urine, with AOPs showing high removal rates.

Limitations and Future Work

  • Cost of Electrochemical Technology: The authors acknowledge that the high cost of electrochemical technology is a major drawback, limiting its current large-scale application.
  • By-product Formation: Electrochemical oxidation can potentially produce toxic by-products like chlorate and perchlorate, requiring careful control of operating conditions.
  • Future Directions: The paper strongly advocates for the coupling of membrane treatment technology with intelligent development (e.g., AI, sensors) to achieve scale and industrialization of source-separated urine treatment. This integrated approach aims to overcome current limitations and enable efficient resource recovery while ensuring environmental safety. Further research is also needed on catalyst development for visible light photocatalysis and a deeper understanding of degradation mechanisms.

Summary updated

Abstract

With the development of world economies and the continuous improvement of living standards, pharmaceutical and personal care products (PPCPs) have attracted significant attention because of their widespread detection in wastewater and the natural environment. Their biological toxicity, environmental persistence, and other hazardous characteristics might pose a threat to the ecological environment and human health. How to treat source-separated urine as a valuable recyclable resource has become a novel challenge. In this review, we briefly described the sources of pharmaceuticals, explored the various metabolic pathways of pharmaceuticals, and concluded that urinary excretion is the primary metabolic pathway of pharmaceuticals. Next, the current status of pharmaceutical contamination in human urine, sewage plants, and surface water was summarized. It is shown that the concentration of pharmaceuticals in human urine is usually 2–3 orders of magnitude higher than that in sewage plants and surface water. Then, the research progress of various technologies to treat pharmaceutical contaminants in urine was analyzed and compared, indicating the promise of advanced oxidation technologies to treat such wastewater, among which electrochemical oxidation has received widespread attention due to its advantages of cleanness, flexibility, and controllability. Therefore, the research progress of electrode materials and electrochemical technology to treat urine was reviewed, and finally, the future development direction was proposed, namely, coupling membrane treatment technology with intellectual development, which will help realize the scale and industrialization of source-separated urine treatment.
BibTeX
@inproceedings{li2023occurrence,
  author = {Xiaolin Li and Bin Wang and Feng Liu and Gang Yu},
  title = {{Occurrence and Removal of Pharmaceutical Contaminants in Urine: A Review}},
  booktitle = {Water},
  year = {2023},
  doi = {10.3390/w15081517},
}
Figure